MS MASTERS en 2024 Bryn Mawr Communications III LLC Tune in for expert lectures on current hot topics in clinical care for MS.  https://megaphone.imgix.net/podcasts/dbb9cf90-db50-11eb-bc3a-07da712493cf/image/ms-masters.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress MS MASTERS no episodic Practical Neurology Tune in for expert lectures on current hot topics in clinical care for MS.  Tune in for expert lectures on current hot topics in clinical care for MS. 

]]> Bryn Mawr Communications (BMC) analytics@bmctoday.com Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Thu, 04 Sep 2025 15:35:00 -0000 full Practical Neurology In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

]]> 784 New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder. Mon, 25 Aug 2025 18:59:00 -0000 full Practical Neurology Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder. Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.

]]> 745 The Optic Nerve in Multiple Sclerosis Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS.  Wed, 26 Feb 2025 21:49:00 -0000 full Practical Neurology Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS.  Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS. 

]]> 682 no Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients. Wed, 11 Dec 2024 14:57:44 -0000 full Practical Neurology In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients. In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.

]]> 922 2024 McDonald Diagnostic Criteria for Multiple Sclerosis Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations. Wed, 20 Nov 2024 13:10:32 -0000 full Practical Neurology Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations. Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations.

]]> 608 10-year Study Data Shows Reduced Disability in MS Patients Treated with Ocrevus Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS. Mon, 15 Jul 2024 17:42:46 -0000 full Practical Neurology Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS. Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.

]]> 666 MS Masters Toolbox: Cramps, Spasms, and Spasticity In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis. Fri, 22 Sep 2023 19:56:00 -0000 full Practical Neurology In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis. In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis.

]]> 1132 MS Masters Toolbox: Balance, Gait and Mobility In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS. Fri, 19 Aug 2022 17:02:00 -0000 full Practical Neurology In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS. In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS.

]]> 1169 Cognitive Dysfunction Description: Dr. Anthony Feinstein of the University of Toronto and Sunnybrook Health Sciences Center in Ontario, Canada and author of the recently released book Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis, shares his expert knowledge and research about cognitive dysfunction in MS and how we are learning to treat this troublesome problem.  Fri, 22 Jul 2022 20:06:00 -0000 full Practical Neurology Description: Dr. Anthony Feinstein of the University of Toronto and Sunnybrook Health Sciences Center in Ontario, Canada and author of the recently released book Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis, shares his expert knowledge and research about cognitive dysfunction in MS and how we are learning to treat this troublesome problem.  Description: Dr. Anthony Feinstein of the University of Toronto and Sunnybrook Health Sciences Center in Ontario, Canada and author of the recently released book Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis, shares his expert knowledge and research about cognitive dysfunction in MS and how we are learning to treat this troublesome problem. 

]]> 1355 MS Masters Toolbox: Fatigue In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 2 provides tools for managing the fatigue that troubles many individuals with MS. Tue, 07 Jun 2022 13:52:07 -0000 full Practical Neurology In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 2 provides tools for managing the fatigue that troubles many individuals with MS. In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 2 provides tools for managing the fatigue that troubles many individuals with MS.

]]> 1156 MS Masters Toolbox: Heat Sensitivity and Exercise Intolerance In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS.  This first episode discusses tools for managing the heat sensitivity and exercise intolerance experienced by many with MS.  Wed, 11 May 2022 18:23:33 -0000 full Practical Neurology In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS.  This first episode discusses tools for managing the heat sensitivity and exercise intolerance experienced by many with MS.  In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. 


This first episode discusses tools for managing the heat sensitivity and exercise intolerance experienced by many with MS. 

]]> 810 Pregnancy and Multiple Sclerosis Dr. Edith Graham of Northwestern University summarizes the current state of knowledge on the use of disease-modifying treatments in women who wish to become or are pregnant including IVF treatment and the postpartum period. Wed, 07 Jul 2021 12:28:54 -0000 full Practical Neurology Dr. Edith Graham of Northwestern University summarizes the current state of knowledge on the use of disease-modifying treatments in women who wish to become or are pregnant including IVF treatment and the postpartum period. Dr. Edith Graham of Northwestern University summarizes the current state of knowledge on the use of disease-modifying treatments in women who wish to become or are pregnant including IVF treatment and the postpartum period.

]]> 1607